ISSN 2500-2236
DOI-prefix: 10.18527/2500-2236

Search


Volume 3, Number 1, 2016
... For the first time, the most important information, concerning the development of a new live modified cold-adapted (ca) equine influenza virus vaccine based on the A/HK/Otar/6:2/2010 strain is summarized ...
Authors: Kaissar Tabynov
Volume 5, Number 1, 2018
... Here, we give an overview of the latest approaches and results in the development of live poultry vaccine candidates against HPAIVs. ...
Authors: Elizaveta Boravleva, Alexandra Gambaryan
Volume 3, Number 1, 2016
... when constructing the reassortant strains for the live attenuated vaccine. ...
Authors: Andrea Wolkerstorfer, Dietmar Katinger, Julia Romanova
Volume 3, Number 1, 2016
... The obtained sera (7 animals per group) were treated with the neuraminidase inhibitor (Denka-Seiken, Japan) and tested for the presence of antibodies to the vaccine virus Len17/H6 in HAI test as described ...
Authors: Yulia A. Desheva, Tatiana A. Smolonogina, Galina O. Landgraf, Larisa G. Rudenko
Volume 4, Number 1, 2017
... inactivated and live attenuated influenza vaccines. ...
Authors: Julia Romanova
Volume 3, Number 1, 2016
... The basic approaches to as well as challenges of creating such a vaccine are discussed in this review. ...
Authors: Andrej Y. Egorov
Том 3, номер 1, 2016
... For the first time, the most important information, concerning the development of a new live modified cold-adapted equine influenza virus vaccine based on the A/HK/Otar/6:2/2010 strain is summarized. ...
Authors: К. К. Табынов
Том 5, номер 1, 2018
... Here, we give an overview of the latest approaches and results in the development of live poultry vaccine candidates against HPAIVs. ...
Authors: Е. Ю. Боравлева, А. С. Гамбарян
Volume 5, Number 1, 2018
... A live intranasal influenza vaccine, which was developed on the basis of the influenza virus with the removed NS1 protein reading frame, has successfully passed clinical trials [ ...
Authors: Kirill A. Vasilyev, Maria A. Yukhneva, Anna-Polina S. Shurygina, Marina A. Stukova, Andrej Y. Egorov
Volume 4, Number 1, 2017
...
A classical way to produce attenuated strains for live influenza vaccine is the reassortment of the epidemic virus ...
Authors: Rustam N. Heydarov, Natalia F. Lomakina, Elizaveta Yu. Boravleva, Ivan S. Kholodilov, Alexandra S. Gambaryan, Vladimir M. Mikhailovich, Eugene E. Fesenko
Том 4, номер 1, 2017
... inactivated and live attenuated influenza vaccines. ...
Authors: Ю.Р. Романова
Volume 5, Number 1, 2018
... Similarly, the vaccination of children with live cold-adapted vaccine showed a decrease in the incidence of otitis media [96]. ...
Authors: Andrej Egorov
Volume 1, number 1, 2014
... Determination of HA content in vaccine preparations The influenza HA antigen content in the vaccine preparations was determined by single radial immuno­diffusion ( ...
Authors: Mariia Sergeeva, Artem Krokhin, Mikhail Matrosovich, Tatyana Matrosovich, Markus Wolschek, Oleg Kiselev, Julia Romanova
Volume 2, Number 1, 2015
... Strains belonging to clade 1 were similar to A/New Caledonia/20/1999 vaccine strain (Fig. 1). ...
Authors: Mikhail P. Grudinin, Maria M. Pisareva, Andrey B. Komissarov, Anna A. Kosheleva, Zhanna V. Buzitskaya, Marina A. Stukova, Alexandra V. Prokopetz, Daria M. Danilenko, Nadezhda I. Konovalova, Tamara G. Lobova, Anna A. Sominina, Oleg I. Kiselev
Volume 6, Number 1, 2019
... For phylogenetic analysis, we selected Ukrainian and European isolates obtained in the course of the study period as well as vaccine and reference strains. ...
Authors: Svetlana V. Babii, Liudmyla V. Leibenko, Larysa V. Radchenko, Olga S. Golubka, Nataliia V. Teteriuk, Alla P. Mironenko
Volume 2, Number 1, 2015
... Petersburg matched the vaccine strains recommended by the WHO for vaccine composition in the 2012-2013 and 2013-2014 seasons.  ...
Authors: Anna A. Sominina, Maria M. Pisareva, Mikhail P. Grudinin, Mikhail Yu. Eropkin, Nadezhda I. Konovalova, Vera F. Sukhovetskaya, Olga I. Afanasieva, Lubov V. Voloshuk, Andrey B. Komissarov, Zhanna V. Buzitskaya, Artem V. Fadeev, Kirill A. Stolyarov, Elizaveta A. Smorodintseva, Veronika S. Afanasieva, Marina A. Yanina, Vitalii V. Gonchar, Ludmila V. Osidak, Alexey A. Go
Том 3, номер 1, 2016
... Basic approaches and challenges in creating such a vaccine are discussed in this review. ...
Authors: А.Ю. Егоров
Том 1, номер 1, 2014
... Virus with modified HA was less susceptible to freezing stress and showed an increased content of immunocompetent HA in inactivated vaccine preparation compared to the analogous virus with original HA. ...
Authors: М.В. Сергеева, А. Крохин, М. Матросович, Т. Матросович, М. Волшек, О.И. Киселев, Ю.Р. Романова
Volume 2, Number 1, 2015
... It is also evident that in the process of anti-influenza vaccine development it is necessary to consider the possibility of the vaccine’s “genetic” orientation toward large population ...
Authors: O. I. Kiselev, A. B. Komissarov, O.S.Konshina, M.N.Dmitrieva, E.G.Deyeva, T.V.Sologub, V.I.Pokrovskiy